Acamprosate Calcium
Active substance: acamprosate
TABLET, DELAYED RELEASE · ACAMPROSATE CALCIUM 333 mg/1
United StatesActive
Marketing holder: Glenmark Pharmaceuticals Inc., USA
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- ACAMPROSATE CALCIUM · 333 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-b7fc-7319-9518-7760b05350e1,01a1208d-a7ca-7447-8e2c-95d923d07bac,01a1208f-2c56-733a-b872-7620db8fe056,01a12090-a439-7013-b021-bd960a9e2183,01a12094-724e-7cb0-b92b-a55d180eb0a1;count=11 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 68462-435
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 68462-435 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 68462-435 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 68462-435 · Verified 2026-10-09 · open in source